WO1999031036A2 - O-derivatives of halogenated diphenyl ether compounds - Google Patents

O-derivatives of halogenated diphenyl ether compounds Download PDF

Info

Publication number
WO1999031036A2
WO1999031036A2 PCT/EP1998/007997 EP9807997W WO9931036A2 WO 1999031036 A2 WO1999031036 A2 WO 1999031036A2 EP 9807997 W EP9807997 W EP 9807997W WO 9931036 A2 WO9931036 A2 WO 9931036A2
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
radical
compounds
sulfo
Prior art date
Application number
PCT/EP1998/007997
Other languages
French (fr)
Other versions
WO1999031036A3 (en
Inventor
Werner Hölzl
Dietmar Hüglin
Thomas Maier
Jianwen Mao
Dietmar Ochs
Original Assignee
Ciba Specialty Chemicals Holding Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Specialty Chemicals Holding Inc. filed Critical Ciba Specialty Chemicals Holding Inc.
Priority to EP98965241A priority Critical patent/EP1042265A2/en
Priority to AU20525/99A priority patent/AU2052599A/en
Publication of WO1999031036A2 publication Critical patent/WO1999031036A2/en
Publication of WO1999031036A3 publication Critical patent/WO1999031036A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/02Monocyclic aromatic halogenated hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds

Definitions

  • the present invention relates to O-derivatives of halogenated diphenyl ether compounds, to a process for the preparation of these compounds, to their use as antimicrobial active substance.
  • halogenated diphenyl ether compounds have an excellent antimicrobial activity. These compounds are therefore widely used, for example as active substances for the antimicrobial finishing of medical items and household articles, as detergent additive and in the hygiene sector, for example in soaps or dental hygiene products.
  • Polymeric materials can be antimicrobially finished by incorporating halogenated diphenyl ether compounds, the active substances being, as a result of their excellent migration properties, constantly conveyed to the surface of the corresponding material ("slow release"). For certain industrial applications, this effect is undesired since the long-term effect of antimicrobially finished materials such as textiles, paper, plastics, cellulose sponges etc. is reduced at the same time.
  • the object of the present invention is thus to provide diphenyl ether compounds which have antimicrobial activity and which, at the same time, are stable to migration.
  • the present invention thus provides O-derivatives of halogenated diphenyl ether compounds of the formula
  • R, and R 2 independently of one another are F, CI or Br; is a radical of the formula (1 a) -(CH 2 ) — CH - 0-R 4 ; (1 b)
  • R 3 is C C 22 alkyl; C.-C ⁇ alkoxy; phenyl; phenyl-C.-C ⁇ lkyl; — (CH 2 ) p - A + R 5 R 6 R 7 ;
  • R 5 , R 6 , R 7 and R 8 independently of one another are hydrogen; C 1 -C 4 all yl; sulfo- C ⁇ C ⁇ Ikyl; or R 5 and R 6 together with A form a cyclic radical unsubstituted or substituted by sulfo groups; or R 7 and R 8 together with N form a cyclic radical unsubstituted or substituted by sulfo groups;
  • A is N or P
  • Z is fluorine, chlorine, the radical of the formula (1 g)
  • Z 2 is fluorine, chlorine, d-Caaalkoxy, C C 22 alkylthio or CrC 22 -monoalkylamino or
  • C C-aadialkylamino each of which is unsubstituted or substituted by OH, NH 2 or sulfo; C 6 -C 12 aryloxy, C 6 -C 12 arylthio or C 6 -C ⁇ 2 monoarylamino or C 6 -C 12 diarylamino, each of which is unsubstituted or substituted by OH, NH 2 or sulfo; m is from 1 to 3; n is 1 or 2; and p p 2 , p 3> p 4 and p 5 independently of one another are 1-4.
  • C.-C ⁇ alkyl and C ⁇ C ⁇ alkoxy are straight-chain or branched alkyl radicals, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl or eicosyl, and methoxy, ethoxy, propoxy, butyloxy, pentyloxy, amyloxy, isoamyloxy, heptyloxy, octyloxy, isooctyloxy, nonyloxy
  • Phenyl-C 1 -C 4 all ⁇ yl is, for example, phenylethyl, phenylpropyl, phenylbutyl or, preferably, benzyl.
  • the derivatives according to the invention are ester, ether or glucoside derivatives of halogenated diphenyl compounds.
  • Preferred ester derivatives are those of the formula
  • R 1t R 2 , R 3 , m and n are as defined in formula (1).
  • R 3 is C.,-C 12 alkyl; or phenyl; and, in particular, to those compounds of the formula (2) in which
  • R, and R 2 are chlorine
  • R 3 is C.-C ⁇ alkyl; m is 1 or 2; and n is 1;
  • Illustrative ester derivatives of halogenated diphenyl compounds according to the invention are those of the formula
  • R 3 is C ⁇ C ⁇ alkyl or phenyl.
  • ester derivatives according to the invention are those of the formulae: o ⁇ n 8
  • R v R 2 , m and n are as defined in formula (1); and R 8 , R 9 and R 10 independently of one another are hydrogen; or C.-C 4 alkyl.
  • Preferred ether derivatives according to the invention are those of the formula
  • R R 2 , R 4 , X, m, n, p, and p 2 are as defined in formula (1 )
  • R 4 is C 1 -C22alkyl. or of the formula
  • ether derivatives according to the invention are those of the formulae (12) v-0 — ,
  • V is a radical of the formula (1 h), preferably (1 i) or (1 k); R 8 , R 9 and R 10 are hydrogen; or C ⁇ C ⁇ Ikyl; and Z, is -O-V; and Z 2 is CI; or N(CH 2 CH 2 OH) 2 .
  • Preferred glucoside derivatives according to the invention are those of the formula
  • V is a radical of the formula (1 h), or, preferably, (1 i) or (1 k).
  • halogenated diphenyl ether derivatives according to the invention which have a phosphate, sulfate or glucoside group are hydrophilic compounds, which are readily obtainable synthetically in high yields.
  • Y is a radical of the formula (1b);
  • R 3 is -(CH 2 ) p4 -N + R 5 R6R 7 ; are obtained in good yields by reacting the chloroacetate of the compound of the formula
  • Sulfobetaines i.e. compounds of the formula (1), in which
  • Y is a radical of the formula (1 b); R 3 is -(CH 2 ) p4 -A-N + R 5 R 6 R 7 ;
  • R 5 is sulfoalkyl; or R 5 and R 6 with A form a cyclic radical, are obtained by reacting corresponding N-dialkyl- or -monoalkylbetaine esters of the compound of the formula (15) with aqueous MSO 3 solution and a suitable catalyst system.
  • Y is a radical of the formula (1f);
  • chlorophosphate the compound of the formula • anc * corresponding amine.
  • the glucoside derivatives are obtainable by reacting the phenolic OH group of the compound of the formula (15) with peracetylated glucose and subsequently hydrolyzing the ester protective groups.
  • the hydrophilic derivatives are colourless, high-melting compounds having good solubility in water.
  • Hydrophobic halogenated diphenyl ether derivatives for example compounds of the formulae (3a), (3b), (10a), (10b) and (11a) and (11b) are obtainable in a single-stage reaction by esterifying or etherifying the phenolic OH group of the compound of the formula (15). Solubility and melting point of the acylated derivatives can be varied within a wide range by the choice of reactant.
  • the diphenyl ether derivatives according to the invention are thermally stable and antimicrobially effective compounds of low volatility and having a severely reduced tendency to migrate. They are therefore preferably suitable for the antimicrobial finishing of polymeric compounds, for example in plastics, rubbers, paints, surface coatings, (textile) fibres which are exposed to a microbially contaminated environment.
  • polymers and other substrates which can be antimicrobially finished in this way are:
  • polyurethanes derived from polyethers, polyesters and polybutadienes having terminal hydroxyl groups on the one hand and aliphatic or aromatic polyisocyanates on the other, and precursors thereof, - polyamides and copolyamides derived from diamines and dicarboxylic acids and/or from aminocarboxylic acids or the corresponding lactams,
  • polyureas polyimides, polyamide-imides. poiyetherimides, polyesterimides, polyhydantoins and polybenzimidazoles,
  • - natural polymers such as cellulose, natural rubber, gelatine, and derivatives thereof modified chemically in a polymer-homologous manner, such as cellulose acetates, cellulose propionates cellulose butyrates, or the cellulose ethers, such as methylcellulose; and also rosins and derivatives.
  • the invention thus also provides a composition
  • a composition comprising
  • the invention also relates to a process for the antimicrobial finishing of an organic material, which comprises adding at least one compound of the formula (1 ) thereto, and to the use of the compound of the formula (1) for the antimicrobial finishing of polymeric materials.
  • the amount of antimicrobial active substance to be used depends on the organic material to be antimicrobially finished and on the intended use of the material finished in this way.
  • the composition according to the invention generally comprises, per 100 parts by weight of component (A), from 0.01 to 15 parts by weight, in particular from 0.05 to 10 parts by weight, and especially from 0.1 to 5 parts by weight of the antimicrobial active substance (component (B)).
  • the antimicrobial active substance (component (B)) can also be a mixture of two or more compounds of the formula (1).
  • the compositions according to the invention can, in addition to the compounds according to the invention, also comprise other additives, for example antioxidants or light protection agents.
  • Incorporation into the organic polymers can take place by adding the halogenated diphenyl ether compound according to the invention and, if desired, other additives by the methods customary in the art. Incorporation can expediently take place before or during shaping, for example by mixing the pulverulent components or by adding the antimicrobial active substance to the melt or solution of the polymer, or by applying the dissolved or dispersed compounds to the polymer, if desired with subsequent evaporation of the solvent.
  • Another method of incorporating the mixtures according to the invention into polymers involves adding the former before or during polymerization of the corresponding monomers or before crosslinking.
  • the mixtures according to the invention can also be added to the organic polymers to be finished in the form of a masterbatch which comprises these compounds, for example, in a concentration of from 2.5 to 25% by weight.
  • the resulting antimicrobially finished polymer compositions can be converted into shaped articles, for example fibres, films, tapes, sheets, multi-wall sheets, containers, tubes and other profiles, by conventional methods, for example by hot pressing, spinning, extrusion or injection moulding.
  • the diphenyl ether derivatives of the formula (1 ) are also suitable for the antimicrobial finishing of undyed and dyed or printed fibre materials made, for example, of silk, wool, polyamide or polyurethane, and in particular of cellulosic fibre materials of all types.
  • Such fibre materials are the natural cellulose fibres, such as cotton, linen, jute and hemp, and also pulp and regenerated cellulose. Preference is given to textile fibre materials made of cotton.
  • the diphenyl ether derivatives according to the invention are also suitable for the antimicrobial finishing of hydroxyl-group-containing fibres which are present in mixed fabrics, for example, of mixtures of cotton with polyester fibres or polyamide fibres.
  • one or more compounds of the formula (1) are advantageously applied to the textile fibre material in an amount of from 0.01 to 5% by weight, preferably 0.1-3% by weight, and in particular from 0.25 to 2% by weight, based on the weight of the fibre material, in a process analogous to dyeing.
  • the diphenyl ether derivatives according to the invention can be applied to the fibre material and fixed to the fibre in different ways, in particular in the form of aqueous dispersions or printing pastes.
  • the textile fibre materials finished using the compounds of the formula (1 ) according to the invention have an excellent and long-lasting antimicrobial protection.
  • the diphenyl ether derivatives according to the invention are also useful for the disinfection of the skin, mucous membrane and hair, preferably for the disinfection of hands and wounds.
  • these compounds are suitable as an antimicrobial active substance in personal care products as shampoos, bath- and shower additives, hair-care products, liquid and bar soaps, lotions and cremes, deodorants, other aqueous or alcoholic solutions, for example cleaning solutions for the skin, moist cleaning sheets, oils and powders.
  • a further subject of the present invention is therefore a personal care composition
  • a personal care composition comprising at least one compound of the formula (1) and cosmetically tolerable carriers or auxiliaries.
  • the personal care composition according to the present invention comprises 0.01 to 15, preferably 0.5 to 10 % b.w. of the diphenyl ether derivative of formula (1) and cosmetically tolerable carriers or auxiliaries.
  • the personal care composition according to the invention can be formulated as a water-in-oil or oil-in-water emulsion, as an oil-in-alcohol lotion, as a vesicular dispersion of an ionic or non-ionic amphiphilic lipid, as a gel, solid stick or as an aerosol formulation.
  • the cosmetically compatible auxiliary preferably contains 5 to 50% of an oil phase, 5 to 20% of an emulsifier and 30 to 90% of water.
  • the oil phase can in this case contain any oil suitable for cosmetic formulations, e.g.
  • hydrocarbon oils one or more hydrocarbon oils, a wax, a natural oil, a silicone oil, a fatty acid ester or a fatty alcohol.
  • Preferred mono- or polyols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.
  • diphenyl ether derivatives according to the invention are useful as household cleaners for the cleaning and disinfection of hard surfaces.
  • Example 8 Determination of the antimicrobial activity of the compound of the formula
  • Test bacteria Staphylococcus aureus ATCC 9144 Escherichia coli NCTC 8196
  • wells having a diameter of 1 cm are cut out using a cork borer (a maximum of 4 wells per plate).
  • 100 ⁇ i of the compound of the formula (102) are poured into each well, and the plates are incubated at 37°C (E. coli and S. aureus for 24 hours). Dilutions of the compound of the formula (102) are prepared in 96% analytical grade ethanol.
  • Example 9 Determination of the antimicrobial activity of the compound of the formula (103) An agar well test corresponding to method CG 126 is carried out with the following modifications:
  • Test bacteria Staphylococcus aureus ATCC 9144 Escherichia coli NCTC 8196
  • Example 10 Determination of the minimum inhibitory concentration (MIC) of the compound of the formula (101):
  • test substances are dissolved in methyl Cellosolve, and a dilution series of the compound of the formula (101) in agar are prepared.
  • the cells are floated out using NaCI solution and adjusted to a density of about 10 6 CFU/ml (live bacterial count).
  • each bacterial suspension 1 ⁇ l of each bacterial suspension is dropped onto the agar plates containing the test substance, and the plates are then incubated at 37°C for 2 days.
  • the bacterial suspensions are applied to agar plates without test substances.
  • the bacterial suspensions are applied to agar plates containing methyl Cellosolve, but without test substance. After the plates have been incubated, the growth of the bacteria on the test-substance-containing plates is compared with that on the control plates.
  • the minimum inhibitory concentration (MIC) is given as the lowest concentration which shows clear inhibition compared with the control.
  • the MIC values are given in the table below.
  • composition (100% active ingredients) % w/w A Compound of formula (102) 1% B Sodium Laureth-2 Sulfate 10.0%
  • (C) is added by stirring to 50% of the calculated amount of the formulation.
  • the suspension is heated up to about 60°C and stirred until (C) is dissolved completely.
  • composition (100% active ingredients) % w/w
  • (C) is added by stirring to 50% of the calculated amount of the formulation.
  • the suspension is heated up to about 60°C and stirred until (C) is dissolved completely.
  • composition (100% active inqredients) % w/w
  • composition (100% active inqredients) % w/w
  • composition (100% active inqredients) % w/w
  • Solution (2) is added to (1) and stirred at maximum speed. Then slowly cool down under continuos stirring. G is added at ⁇ 40°C.
  • composition (100% active ingredients) % w/w
  • Solution (2) is added to (1 ) and stirred at maximum speed. Then slowly cool down under continuos stirring. (G) is added at ⁇ 40°C.
  • Example 17 Preparation of a liguid laundry detergent
  • composition (100% active ingredients) % w/w
  • composition (100% active inqredients) % w/w
  • composition (100% active ingredients) % w/w
  • Non-ionic surfactants 2.9%
  • Example 20 Preparation of a laundry detergent powder
  • composition (100% active ingredients) % w/w
  • Non-ionic surfactants 2.9%
  • composition (100% active ingredients) % w/w
  • Example 22 10 grams of the compound of formula (102) is added into 45 grams of low density polyethylene (Escorene LL6301 XR, from Exxon) and 45 grams of low density polyethylene (Escorene LL6301 RQ, from Exxon). The mixture is tumble mixed for 10 minutes followed by addition into a 29mm twin-extruder to produce a master batch. The extrusion temperature is set at 180°C.
  • Example 23 10 gram of the resulting master batch (contains 10% of compound of formula 102) in Example 22 is added into 90 grams of low density polyethylene pellets (Escorene LL6301 XR, from Exxon) and well mixed. The mixture is then charged into an injection moulding machine to produce low density polyethylene plates (10 x 20 cm, thickness 2mm). The resulting low density polyethylene plates contain 1% of compound of formula (102). The plates are then cut into discs of 2 cm in diameter and tested for antimicrobial efficacy in agar diffusion test by using the same procedures as described in Example 8.
  • low density polyethylene pellets Escorene LL6301 XR, from Exxon

Abstract

The invention describes O-derivatives of halogenated diphenyl ether compounds of formula (1), in which R1 and R2 independently of one another are F, Cl or Br; Y is a radical of formula (1a); (1b); (1c); (1d); (1e) or (1f); R3 is C1-C22alkyl; C1-C22alkoxy; phenyl; phenyl-C1-C4alkyl; --(CH2)p4-A+R5R6R7; the radical of formula (I); R4 C1-C22alkyl; R5, R6, R7 and R8 independently of one another are hydrogen; C1-C4alkyl; sulfo-C1-C4alkyl; or R5 and R6 together with A form a cyclic radical unsubstituted or substituted by sulfo groups; or R7 and R8 together with N form a cyclic radical unsubstituted or substituted by sulfo groups; A is N or P; Z1 is fluorine, chlorine, the radical of formula (1g); Z2 is fluorine, chlorine, C1-C22alkoxy, C1-C22alkylthio or C1-C22-monoalkylamino or C1-C22dialkylamino; each of which is unsubstituted or substituted by OH, NH2 or sulfo; C6-C12aryloxy, C6-C12arylthio or C6-C12monoarylamino or C6-C12diarylamino, each of which is unsubstituted or substituted by OH, NH2 or sulfo; m is from 1 to 3; n is 1 or 2; and p1, p2, p3, p4 and p5 independently of one another are 1-4. The diphenyl ether derivatives according to the invention have excellent antimicrobial properties and are stable to migration.

Description

O-Derivatives of halogenated diphenyl ether compounds
The present invention relates to O-derivatives of halogenated diphenyl ether compounds, to a process for the preparation of these compounds, to their use as antimicrobial active substance.
It is known that certain halogenated diphenyl ether compounds have an excellent antimicrobial activity. These compounds are therefore widely used, for example as active substances for the antimicrobial finishing of medical items and household articles, as detergent additive and in the hygiene sector, for example in soaps or dental hygiene products. Polymeric materials can be antimicrobially finished by incorporating halogenated diphenyl ether compounds, the active substances being, as a result of their excellent migration properties, constantly conveyed to the surface of the corresponding material ("slow release"). For certain industrial applications, this effect is undesired since the long-term effect of antimicrobially finished materials such as textiles, paper, plastics, cellulose sponges etc. is reduced at the same time.
The object of the present invention is thus to provide diphenyl ether compounds which have antimicrobial activity and which, at the same time, are stable to migration.
Surprisingly, it has been found that certain derivatives of halogenated diphenyl ether compounds satisfy this requirement.
The present invention thus provides O-derivatives of halogenated diphenyl ether compounds of the formula
Figure imgf000003_0001
in which
R, and R2 independently of one another are F, CI or Br; is a radical of the formula (1 a) -(CH2) — CH - 0-R4 ; (1 b)
Figure imgf000004_0001
(1 c) -(CH2)
Figure imgf000004_0002
O R5 or (1 f) _ p _ o - (CH2) - N - R6 • O R7
R3 is C C22alkyl; C.-C^ alkoxy; phenyl; phenyl-C.-C^lkyl; — (CH2)p - A+R5R6R7 ;
4
. the radical of the formula ;
I
Figure imgf000004_0003
COO'
R4 0,-022311^1;
R5, R6, R7 and R8 independently of one another are hydrogen; C1-C4all yl; sulfo- C^C^Ikyl; or R5 and R6 together with A form a cyclic radical unsubstituted or substituted by sulfo groups; or R7 and R8 together with N form a cyclic radical unsubstituted or substituted by sulfo groups;
A is N or P;
Z, is fluorine, chlorine, the radical of the formula (1 g)
Figure imgf000004_0004
(R2)n
Z2 is fluorine, chlorine, d-Caaalkoxy, C C22alkylthio or CrC22-monoalkylamino or
C C-aadialkylamino; each of which is unsubstituted or substituted by OH, NH2 or sulfo; C6-C12aryloxy, C6-C12arylthio or C6-Cι2monoarylamino or C6-C12diarylamino, each of which is unsubstituted or substituted by OH, NH2 or sulfo; m is from 1 to 3; n is 1 or 2; and p p2, p3> p4 and p5 independently of one another are 1-4.
C.-C^alkyl and C^C^alkoxy are straight-chain or branched alkyl radicals, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, hexyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl or eicosyl, and methoxy, ethoxy, propoxy, butyloxy, pentyloxy, amyloxy, isoamyloxy, heptyloxy, octyloxy, isooctyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tetradecyloxy, pentadecyloxy, hexadecyloxy, heptadecyloxy, octadecyloxy or eicosyloxy respectively.
Phenyl-C1-C4all<yl is, for example, phenylethyl, phenylpropyl, phenylbutyl or, preferably, benzyl.
The derivatives according to the invention are ester, ether or glucoside derivatives of halogenated diphenyl compounds.
Preferred ester derivatives are those of the formula
Figure imgf000005_0001
in which R1t R2, R3, m and n are as defined in formula (1).
Particular preference is given to compounds of the formula (2) in which
R3 is C.,-C12alkyl; or phenyl; and, in particular, to those compounds of the formula (2) in which
R, and R2 are chlorine;
R3 is C.-C^alkyl; m is 1 or 2; and n is 1; Illustrative ester derivatives of halogenated diphenyl compounds according to the invention are those of the formula
Figure imgf000006_0001
in which R3 is C^C^alkyl or phenyl.
Other suitable ester derivatives according to the invention are those of the formulae: o β n 8
(4) A_ 0j^ _ Rg ; (5) A_0_^ _ R
CH R CH-
10 10
(6)
Figure imgf000006_0002
in which
is the radical of the formula (1 h) ; or, preferably,
Figure imgf000006_0003
Figure imgf000006_0004
Rv R2, m and n are as defined in formula (1); and R8, R9 and R10 independently of one another are hydrogen; or C.-C4alkyl.
Preferred ether derivatives according to the invention are those of the formula
Figure imgf000006_0005
CH
Figure imgf000007_0001
in which
R R2, R4, X, m, n, p, and p2 are as defined in formula (1 )
Very particularly preferred ether derivatives are those of the formula
Figure imgf000007_0002
in which
R4 is C1-C22alkyl. or of the formula
Figure imgf000007_0003
Other ether derivatives according to the invention are those of the formulae (12) v-0 — ,
Figure imgf000008_0001
in which
V is a radical of the formula (1 h), preferably (1 i) or (1 k); R8, R9 and R10 are hydrogen; or C^C^Ikyl; and Z, is -O-V; and Z2 is CI; or N(CH2CH2OH)2.
Preferred glucoside derivatives according to the invention are those of the formula
Figure imgf000008_0002
in which
V is a radical of the formula (1 h), or, preferably, (1 i) or (1 k).
The halogenated diphenyl ether derivatives according to the invention which have a phosphate, sulfate or glucoside group are hydrophilic compounds, which are readily obtainable synthetically in high yields.
Compounds of the formula (1 ) in which
Y is a radical of the formula (1b);
R3 is -(CH2)p4-N+R5R6R7; are obtained in good yields by reacting the chloroacetate of the compound of the formula
Figure imgf000008_0003
with primary, secondary and tertiary amines. The preparation of these compounds when R3 is -(CH2)p4-P+R5R6R is analogous.
Sulfobetaines, i.e. compounds of the formula (1), in which
Y is a radical of the formula (1 b); R3 is -(CH2)p4-A-N+R5R6R7;
R5 is sulfoalkyl; or R5and R6 with A form a cyclic radical, are obtained by reacting corresponding N-dialkyl- or -monoalkylbetaine esters of the compound of the formula (15) with aqueous MSO3 solution and a suitable catalyst system.
Compounds of the formula (1) in which
Y is a radical of the formula (1f); and
are obtainable, for example, by reacting the compound of the formula (15) with ethylene
chlorophosphate, the compound of the formula anc* corresponding amine.
Figure imgf000009_0001
The glucoside derivatives (compounds of the formula (14)) are obtainable by reacting the phenolic OH group of the compound of the formula (15) with peracetylated glucose and subsequently hydrolyzing the ester protective groups.
The hydrophilic derivatives are colourless, high-melting compounds having good solubility in water.
Hydrophobic halogenated diphenyl ether derivatives, for example compounds of the formulae (3a), (3b), (10a), (10b) and (11a) and (11b) are obtainable in a single-stage reaction by esterifying or etherifying the phenolic OH group of the compound of the formula (15). Solubility and melting point of the acylated derivatives can be varied within a wide range by the choice of reactant.
Compounds of the formula (1), in which Y is a radical of the formula (1 a) or (1 c); R R2, m and n are as defined in formula(1), can be obtained by etherification of the phenolic OH group of the compound of the formula
Figure imgf000010_0001
with the corresponding halide compound.
The diphenyl ether derivatives according to the invention are thermally stable and antimicrobially effective compounds of low volatility and having a severely reduced tendency to migrate. They are therefore preferably suitable for the antimicrobial finishing of polymeric compounds, for example in plastics, rubbers, paints, surface coatings, (textile) fibres which are exposed to a microbially contaminated environment.
Examples of polymers and other substrates which can be antimicrobially finished in this way are:
- polymers of mono- and diolefins,
- polyolefins,
- copolymers of mono- and diolefins with one another or with other vinyl monomers,
- hydrocarbon resins,
- polystyrene,
- copolymers of styrene or α-methylstyrene or dienes or acrylic derivatives,
- graft copolymers of styrene or α-methylstyrene.
- halogen-containing polymers,
- polymers derived from α,β-unsaturated acids and derivatives thereof, such as polyacrylates and polymethacrylates,
- polymers derived from unsaturated alcohols and amines or acyl derivatives or acetals thereof,
- homo- and copolymers of cyclic ethers, polyacetals, polyphenylene oxides and polyphenylene sulfides and mixtures thereof with styrene polymers or polyamides,
- polyurethanes derived from polyethers, polyesters and polybutadienes having terminal hydroxyl groups on the one hand and aliphatic or aromatic polyisocyanates on the other, and precursors thereof, - polyamides and copolyamides derived from diamines and dicarboxylic acids and/or from aminocarboxylic acids or the corresponding lactams,
- polyureas, polyimides, polyamide-imides. poiyetherimides, polyesterimides, polyhydantoins and polybenzimidazoles,
- polyesters,
- polycarbonates and polyester carbonates,
- polysulfones, polyether sulfones and polyether ketones,
- crosslinked polymers derived from aldehydes on the one hand and phenols, urea or melamine on the other hand, such as phenol-formaldehyde resins, urea-formaldehyde resins and melamine-formaldehyde resins,
- drying and non-drying alkyd resins,
- unsaturated polyester resins,
- crosslinkable acrylic resins,
- alkyd resins, polyester resins and acrylate resins,
- crosslinked epoxy resins,
- natural polymers, such as cellulose, natural rubber, gelatine, and derivatives thereof modified chemically in a polymer-homologous manner, such as cellulose acetates, cellulose propionates cellulose butyrates, or the cellulose ethers, such as methylcellulose; and also rosins and derivatives.
The invention thus also provides a composition comprising
(A) an organic material to be antimicrobially finished and
(B) a compound of the formula (1 ).
The invention also relates to a process for the antimicrobial finishing of an organic material, which comprises adding at least one compound of the formula (1 ) thereto, and to the use of the compound of the formula (1) for the antimicrobial finishing of polymeric materials.
The amount of antimicrobial active substance to be used depends on the organic material to be antimicrobially finished and on the intended use of the material finished in this way. The composition according to the invention generally comprises, per 100 parts by weight of component (A), from 0.01 to 15 parts by weight, in particular from 0.05 to 10 parts by weight, and especially from 0.1 to 5 parts by weight of the antimicrobial active substance (component (B)). The antimicrobial active substance (component (B)) can also be a mixture of two or more compounds of the formula (1). The compositions according to the invention can, in addition to the compounds according to the invention, also comprise other additives, for example antioxidants or light protection agents.
Incorporation into the organic polymers, for example into the synthetic organic, in particular thermoplastic, polymers can take place by adding the halogenated diphenyl ether compound according to the invention and, if desired, other additives by the methods customary in the art. Incorporation can expediently take place before or during shaping, for example by mixing the pulverulent components or by adding the antimicrobial active substance to the melt or solution of the polymer, or by applying the dissolved or dispersed compounds to the polymer, if desired with subsequent evaporation of the solvent. Another method of incorporating the mixtures according to the invention into polymers involves adding the former before or during polymerization of the corresponding monomers or before crosslinking.
The mixtures according to the invention can also be added to the organic polymers to be finished in the form of a masterbatch which comprises these compounds, for example, in a concentration of from 2.5 to 25% by weight.
The resulting antimicrobially finished polymer compositions can be converted into shaped articles, for example fibres, films, tapes, sheets, multi-wall sheets, containers, tubes and other profiles, by conventional methods, for example by hot pressing, spinning, extrusion or injection moulding.
The diphenyl ether derivatives of the formula (1 ) are also suitable for the antimicrobial finishing of undyed and dyed or printed fibre materials made, for example, of silk, wool, polyamide or polyurethane, and in particular of cellulosic fibre materials of all types. Examples of such fibre materials are the natural cellulose fibres, such as cotton, linen, jute and hemp, and also pulp and regenerated cellulose. Preference is given to textile fibre materials made of cotton. The diphenyl ether derivatives according to the invention are also suitable for the antimicrobial finishing of hydroxyl-group-containing fibres which are present in mixed fabrics, for example, of mixtures of cotton with polyester fibres or polyamide fibres. For this purpose, one or more compounds of the formula (1) are advantageously applied to the textile fibre material in an amount of from 0.01 to 5% by weight, preferably 0.1-3% by weight, and in particular from 0.25 to 2% by weight, based on the weight of the fibre material, in a process analogous to dyeing.
The diphenyl ether derivatives according to the invention can be applied to the fibre material and fixed to the fibre in different ways, in particular in the form of aqueous dispersions or printing pastes.
The textile fibre materials finished using the compounds of the formula (1 ) according to the invention have an excellent and long-lasting antimicrobial protection.
The diphenyl ether derivatives according to the invention are also useful for the disinfection of the skin, mucous membrane and hair, preferably for the disinfection of hands and wounds.
Therefore, these compounds are suitable as an antimicrobial active substance in personal care products as shampoos, bath- and shower additives, hair-care products, liquid and bar soaps, lotions and cremes, deodorants, other aqueous or alcoholic solutions, for example cleaning solutions for the skin, moist cleaning sheets, oils and powders.
A further subject of the present invention is therefore a personal care composition comprising at least one compound of the formula (1) and cosmetically tolerable carriers or auxiliaries.
The personal care composition according to the present invention comprises 0.01 to 15, preferably 0.5 to 10 % b.w. of the diphenyl ether derivative of formula (1) and cosmetically tolerable carriers or auxiliaries.
The personal care composition according to the invention can be formulated as a water-in-oil or oil-in-water emulsion, as an oil-in-alcohol lotion, as a vesicular dispersion of an ionic or non-ionic amphiphilic lipid, as a gel, solid stick or as an aerosol formulation. As a water-in-oil or oil-in-water emulsion, the cosmetically compatible auxiliary preferably contains 5 to 50% of an oil phase, 5 to 20% of an emulsifier and 30 to 90% of water. The oil phase can in this case contain any oil suitable for cosmetic formulations, e.g. one or more hydrocarbon oils, a wax, a natural oil, a silicone oil, a fatty acid ester or a fatty alcohol. Preferred mono- or polyols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.
Furthermore the diphenyl ether derivatives according to the invention are useful as household cleaners for the cleaning and disinfection of hard surfaces.
The examples below serve to illustrate the invention.
Preparation Examples of novel compounds
Example 1 : Reaction equation:
Figure imgf000015_0001
9.0 g (14.5 mmol) of the compound of the formula (101a) are dissolved in 120 ml of methanol. 0.2 ml (1.08 mmol) of an approximately 30% NaOCH3 solution is then added, and the mixture is stirred at room temperature for 2 hours. After 30 minutes, the reaction is virtually complete. A yellow-red solution forms, which is evaporated to give 6.72 g of a beige- reddish substance, which corresponds to the compound of the formula (101), which is purified by column chromatography (column: CHCl3/MeOH 10:1). Yield: 5.87 g
Elemental analysis:
Calculated Found
C 47.86 % 47.4 %
H 3.79 % 3.8 %
CI 23.55 % 23.5 %
Example 2: Reaction equation:
Figure imgf000016_0001
(102a) (102)
14.5 g (50 mmol) of the compound of the formula (102a) are dissolved in 100 ml of a xylene isomer mixture and 3.96 g (50 mmol) of pyridine. The mixture is heated to 130°C, and
11.16 g (50 mmol) of lauroyl chloride, diluted with 20 ml of xylene isomer mixture, are added dropwise over the course of 20 minutes. The mixture is left to cool to room temperature,
150 ml of water are added and the pH is adjusted to slightly acidic using 2 n HCI. The organic phase is separated off using a separating funnel, washed with 1 x 150 ml of water, dried over Na2SO4 and evaporated to dryness.
This gives 23.5 g of crude product of the compound of the formula (102), which is distilled under a high vacuum.
Yield: 20.9 g; b.p.: 215-220°C/0.02 torr.
Example 3: Reaction equation:
Figure imgf000016_0002
72.4 g (25 mmol) of the compound of the formula (102a) are dissolved in 500 ml of methyl Cellosolve at 80°C. 26.5 g (25 mmol) of Na2CO3 are stirred into this solution at 80°C. The solution is then stirred for 30 minutes at from 80 to 85°C. 25.5 g (25 mmol) of epichlorohydrin, which is diluted with 25 ml of methyl Cellosolve, is then added dropwise with stirring over the course of 45 minutes at a temperature of from 80 to 85°C. The warm solution is then decanted and evaporated to dryness. The residue is dissolved in 300 ml of toluene, filtered and extracted by shaking twice with water, dried over Na2SO4 and evaporated to dryness. Yield:89.8q
Example 4: Reaction equation:
Figure imgf000017_0001
Figure imgf000017_0002
(104)
8.7 g (30 mmol) of the compound of the formula (102a) are introduced into 100 ml of xylene isomer mixture. 8.2 g (30 mmol) of the 1 :1 isomer mixture of the formulae
O O
/ \ / \
(104a) H3C - (CH2)11 - O - CH2 - CH - CH2 and (104b) H3C - (CH2)12 - O - CH2 - CH - CH2 , and 0.5 g of ethyltriphenylphosphonium bromide are added over the course of 8.5 hours at a temperature of from 130 to 140°C.
After the reaction has ended, the mixture is left to cool to 100°C and 100 ml of water are added, the mixture is thoroughly stirred, and the organic phase is separated off, dried over
Na2SO4 and evaporated to dryness.
Yield: 18.2 g of the 1 :1 mixture of the compound of the formula (104). Example 5: Reaction equation:
Figure imgf000018_0001
(105)
29.0 g (0.1 mol) of the compound of the formula (102a) and 9.2 g (0.05 mol) of cyanuric chloride are dissolved in 150 ml of toluene. At 0°C, 6.1 g of coliidine are added dropwise, as a result of which, the temperature increases to 10°C. The reaction is then completed by stirring the mixture for 12 hours at room temperature. After the reaction composition has been quenched with 500 ml of water, the organic phase is separated off, washed with 200 ml of water and dried over sodium sulfate. The solvent is stripped off to give the compound of the formula (105) as a viscous oil, which crystallizes at 0°C after some time.
Purity (HPLC, F%): 80%) Yield: 15.0 g
Example 6: Reaction equation:
Figure imgf000018_0002
(106)
24.9 g (0.1 mol) of the compound of the formula (107) and 9.2 g (0.05 mol) of cyanuric chloride are dissolved in 150 ml of toluene. At 0°C, 6.1 g of coliidine are added dropwise, as a result of which the temperature increases to 10°C. The reaction is then completed by a result of which the temperature increases to 10°C. The reaction is then completed by stirring the mixture for 12 hours at room temperature. After the reaction composition has been quenched with approximately 500 ml of water, the organic phase is separated off, washed with 200 ml of water and dried over sodium sulfate. The solvent is stripped off to give the compound of the formula (106) as a colourless oil which crystallizes slowly at 0°C.
Purity (HPLC, F%): 85% Yield: 14.5 g
Example 7: Reaction equation:
Figure imgf000019_0001
(107) (108)
62.3 g (0.25 mol) of the compound of the formula (107) are dissolved in 500 ml of methyl Cellosolve at 80°C. 26.5 g (0.25 mol) of Na2CO3 are stirred into this solution at 80°C. The solution is then stirred for 30 minutes at from 80 to 85°C. 25.5 g (0.25 mol) of epichlorohydrin, which is diluted with 25 ml of methyl Cellosolve, is then added dropwise with stirring over the course of 45 minutes at a temperature of from 80 to 85°C. The warm solution is then decanted off from the insoluble matter and evaporated to dryness. The residue is taken up in 300 ml of toluene and the solution is filtered, extracted by shaking twice with water, dried over sodium sulfate and evaporated to dryness. Yield: 85.4g Application Examples:
Example 8: Determination of the antimicrobial activity of the compound of the formula
11321
Test method:
An agar well test is carried out (method CG 126) with the following modifications:
Medium: Casein soybean flour peptone agar (Caso-agar)
Test bacteria: Staphylococcus aureus ATCC 9144 Escherichia coli NCTC 8196
Procedure: 500ml of Caso-agar are inoculated with 3.5 ml of a 1 :100 diluted overnight culture of the bacteria, and plates with a volume of about 18 ml are poured.
After the plates have cooled, wells having a diameter of 1 cm are cut out using a cork borer (a maximum of 4 wells per plate). 100 μi of the compound of the formula (102) are poured into each well, and the plates are incubated at 37°C (E. coli and S. aureus for 24 hours). Dilutions of the compound of the formula (102) are prepared in 96% analytical grade ethanol.
Results:
Figure imgf000020_0001
The zones of inhibition are observed after incubation for 24 hours. The results in Table 1 show that the compound of the formula (102) has excellent antimicrobial activity. Example 9: Determination of the antimicrobial activity of the compound of the formula (103) An agar well test corresponding to method CG 126 is carried out with the following modifications:
Medium: Casein soybean flour peptone agar (Caso-agar)
Test bacteria: Staphylococcus aureus ATCC 9144 Escherichia coli NCTC 8196
Procedure: 500 ml of Caso-agar are inoculated with 3.5 ml of a 1 :100 diluted overnight culture of the bacteria, and Caso plates (18 ml) are coated with about 5 ml of the bacteria-containing agar.
After the plates have cooled, wells having a diameter of 1 cm are cut out using a cork borer (one well per plate; all test substance concentrations are tested twice).
100 μl of the compound of the formula (103) (in 96% ethanol) are poured into each well, and the plates are incubated at 37°C for about 24 hours.
The results are given in Table 2.
Figure imgf000021_0001
All dilutions are tested twice and both results are given in the table. The results show that the compound of the formula (103) has excellent bacteriostatic activity.
Example 10: Determination of the minimum inhibitory concentration (MIC) of the compound of the formula (101):
An agar incorporation test is carried out to determine the MIC:
Medium: Nutrient agar as test agar for bacteria:
Casein soybean flour peptone agar to cultivate the microorganisms 0.9% sodium chloride (pH 7.2) for obtaining the bacterium suspension Methyl Cellosolve as solvent
Test bacteria Escherichia coli NCTC 8196 Pseudomonas aeruginosa CIP A-22 Serratia marcescens ATCC 14756 Enterococcus faecium ATTC 10'541 Staphylococcus aureus ATCC 9144 Candida albicans ATCC 10'23q
Procedure: The test substances are dissolved in methyl Cellosolve, and a dilution series of the compound of the formula (101) in agar are prepared.
After the cultures have been cultivated on casein soybean flour peptone agar, the cells are floated out using NaCI solution and adjusted to a density of about 106 CFU/ml (live bacterial count).
1 μl of each bacterial suspension is dropped onto the agar plates containing the test substance, and the plates are then incubated at 37°C for 2 days. As controls, the bacterial suspensions are applied to agar plates without test substances. In order to exclude the solvent methyl Cellosolve having an influence on the growth properties, the bacterial suspensions are applied to agar plates containing methyl Cellosolve, but without test substance. After the plates have been incubated, the growth of the bacteria on the test-substance-containing plates is compared with that on the control plates.
The minimum inhibitory concentration (MIC) is given as the lowest concentration which shows clear inhibition compared with the control.
The MIC values are given in the table below.
Figure imgf000023_0001
The results in Table 3 clearly show that the compound of the formula (101) has antimicrobial activity.
Preparation of formulations
Example 11 : Preparation of a liquid hand soap
Composition (100% active ingredients) % w/w A Compound of formula (102) 1% B Sodium Laureth-2 Sulfate 10.0%
Sodium Cumene sulfonate 3.0% C Hydroxypropylmethylcellulose 1.0% D Perfume / Dyestuff q.s. E Ethanolamine up to pH 5.5 F Deionized water to 100.0% Preparation procedure:
At room temperature, (C) is added by stirring to 50% of the calculated amount of the formulation. The suspension is heated up to about 60°C and stirred until (C) is dissolved completely.
Compounds of (B) are dissolved in 15% of the calculated amount of formulation by stirring and heating up to about 60°C until a clear solution is formed.
(A) is added to solution B, pH is adjusted with E to about 5.0. Solution (C) is added and after stirring the pH is adjusted to 5.5 with (E). F is added to 100%.
Example 12: Preparation of a liquid hand soap
Composition (100% active ingredients) % w/w
A Compound of formula (101 ) 1 %
B Sodium Laureth-2 Sulfate 10.0%
Sodium Cumene sulfonate 3.0%
C Hydroxypropylmethylcellulose 1.0%
D Perfume / Dyestuff q.s.
E Ethanolamine up to pH 5.5
F Deionized water to 100.0%
Preparation procedure
At room temperature, (C) is added by stirring to 50% of the calculated amount of the formulation. The suspension is heated up to about 60°C and stirred until (C) is dissolved completely.
Compounds of (B) are dissolved in 15% of the calculated amount of formulation by stirring and heating up to about 60°C until a clear solution is formed.
(A) is added to solution (B), pH is adjusted with (E) to about 5.0. Solution (C) is added and after stirring the pH is adjusted to 5.5 with (E). F is added to 100%.
Example 13: Preparation of a natural bar soap
Composition (100% active inqredients) % w/w
A Compound of formula (102) 0.5%
B Sodium tallowate 90.0%
Sodium cocoate
C Stearic acid 3.0%
D Titanium dioxide 0.3%
E Tetrasodium EDTA 0.03%
F Glycerine 3.0%
G Perfume q.s.
H Deion. water ad 100.0%
Example 14: Preparation of a natural bar soap
Composition (100% active inqredients) % w/w
A Compound of formula (101 ) 0.7%
B Sodium tallowate 93.0%
Sodium cocoate
C Titanium dioxide 0.3%
D Tetrasodium EDTA 0.03%
E Glycerine 3.0%
F Perfume q.s.
G Deion. water ad 100.0% Example 15: Preparation of a deodorant roll-on
Composition (100% active inqredients) % w/w
A Compound o formula (102) 0.3%
B Steareth-10 4.0%
C PPG-25 Laureth-25 5.0%
D Cetylalcohol 2.0%
E Mineral Oil 9.0%
F Propylene Glycol 4.0%
G Preservatives / Perfume / Dyestuff q.s.
H Deionized water to 100.0%
Preparation procedure for Examples 13-15:
1. (A) is dissolved in F. E and B are added and the mixture is stirred homogeneous.
(D) is added, the suspension is heated up to -70°C and stirred until D is melted.
2. (C) is added to the calculated amount of H, the solution is heated to ~70°C.
3. Solution (2) is added to (1) and stirred at maximum speed. Then slowly cool down under continuos stirring. G is added at ~40°C.
Example 16: Preparation of a Deodorant Roll-on
Composition (100% active ingredients) % w/w
A Compound of formula (101) 0.3%
B Steareth-10 4.0%
C PPG-25 Laureth-25 5.0%
D Cetylalcohol 2.0%
E Mineral Oil 9.0%
F Propylene Glycol 4.0%
G Preservatives / Perfume / Dyestuff q.s.
H Deionized water to 100.0% Preparation procedure:
1. (A) is dissolved in (F). (E) and (B) are added and the mixture is stirred homogeneous.
(D) is added, the suspension is heated up to ~70°C and stirred until (D) is melted.
2. (C) is added to the calculated amount of H, the solution is heated to ~70°C.
3. Solution (2) is added to (1 ) and stirred at maximum speed. Then slowly cool down under continuos stirring. (G) is added at ~40°C.
Example 17: Preparation of a liguid laundry detergent
Composition (100% active ingredients) % w/w
A Compound of formula (105) 1%
B PEG-7 C14-15 alcohol ether 15%
Sodium Dodecylbenzenesulfonate 10.0%
Propylene Glycol 10.0%
C Deionized water to 100.0%
Preparation procedure:
Dissolve (A) in (B) and 25% of (C).
Add (C) up to 100%
Example 18: Preparation of a liguid laundry detergent
Composition (100% active inqredients) % w/w
A Compound of formula (106) 1 %
B PEG-7 C14-15 alcohol ether 15%
Sodium Dodecylbenzenesulfonate 10.0%
Propylene Glycol 10.0%
C Deionized water to 100.0%
Preparation procedure:
Dissolve (A) in (B) and 25% of (C).
Add (C) up to 100% Example 19: Preparation of a laundry detergent powder
Composition (100% active ingredients) % w/w
A Compound of formula (105) 0.3%
B Lauryl ammonium sulfate 8.0%
Non-ionic surfactants 2.9%
Soaps 3.5%
Sodium tripolyphosphate 43.8%
Sodium silicate 7.5%
Magnesium silicate 1.9%
Carboxymethylcellulose 1.2%
EDTA 0.2%
Sodium sulfate 21.2%
Water to 100%
Example 20: Preparation of a laundry detergent powder
Composition (100% active ingredients) % w/w
A Compound of formula (106) 0.3%
B Lauryl ammonium sulfate 8.0%
Non-ionic surfactants 2.9%
Soaps 3.5%
Sodium tripolyphosphate 43.8%
Sodium silicate 7.5%
Magnesium silicate 1.9%
Carboxymethylcellulose 1.2%
EDTA 0.2%
Sodium sulfate 21.2%
Water to 100% Example 21 : Preparation of a dish washing detergent
Composition (100% active ingredients) % w/w
A Compound of formula (102) 0.5%
B Sodium lauryl sulfate 7.0%
C Sodium myrethsulfate 7.0%
D Lauryl glucoside 4.0%
E Coco betaine 1.1%
F Ethanol 5.0%
G Citric acid 1.0%
H Water to 100%
Preparation procedure of Examples 19-21 :
1. (B), (C), (D) and (E) are dissolved in part of H at 40°C.
2. (A) is added and stirred at 40°C.
3. (F) and (G) and the rest of (H) is added at 22°C. 4.pH is adjusted to 5.
Example 22: 10 grams of the compound of formula (102) is added into 45 grams of low density polyethylene (Escorene LL6301 XR, from Exxon) and 45 grams of low density polyethylene (Escorene LL6301 RQ, from Exxon). The mixture is tumble mixed for 10 minutes followed by addition into a 29mm twin-extruder to produce a master batch. The extrusion temperature is set at 180°C.
Example 23: 10 gram of the resulting master batch (contains 10% of compound of formula 102) in Example 22 is added into 90 grams of low density polyethylene pellets (Escorene LL6301 XR, from Exxon) and well mixed. The mixture is then charged into an injection moulding machine to produce low density polyethylene plates (10 x 20 cm, thickness 2mm). The resulting low density polyethylene plates contain 1% of compound of formula (102). The plates are then cut into discs of 2 cm in diameter and tested for antimicrobial efficacy in agar diffusion test by using the same procedures as described in Example 8.
The results are listed in Table 4.
Figure imgf000030_0001
The test results show that the compound of formula (102) shows a good antimicrobial efficacy.

Claims

WHAT IS CLAIMED IS:
1. An O-derivative of a halogenated diphenyl ether compound of the formula
, in which
Figure imgf000031_0001
R1 and R2 independently of one another are F, CI or Br;
Y is a radical of the formula ;
Figure imgf000031_0002
0┬░) , -(CH2,)
Figure imgf000031_0003
Figure imgf000031_0004
R3 is C^C^alkyl; C^C^alkoxy; phenyl; phenyl-C^C^Ikyl; ΓÇö (CH2)p - A+R5R6R7 ;
4
the radical of the formula
Figure imgf000031_0005
R4 C1-C22alkyl;
R5, R6, R7 and R8 independently of one another are hydrogen; C1-C4all yl; sulfo- C.-C4alkyl; or R5 and R6 together with A form a cyclic radical unsubstituted or substituted by sulfo groups; or R7 and R8 together with N form a cyclic radical unsubstituted or substituted by sulfo groups;
A is N or P; Z, is fluorine, chlorine, the radical of the formula (1g) or Z?
Figure imgf000032_0001
Z2 is fluorine, chlorine, CrC22alkoxy, CrC^alkylthio or C╬╣-C22-monoalkylamino or C C22dialkylamino; each of which is unsubstituted or substituted by OH, NH2 or sulfo; C6- C12aryloxy, C6-C12arylthio or C6-C12monoarylamino or C6-C╬╣2diarylamino, each of which is unsubstituted or substituted by OH, NH2 or sulfo; m is from 1 to 3; n is 1 or 2; and pv p2, p3> p4 and p5 independently of one another are 1-4.
2. A compound according to claim 1 of the formula
Figure imgf000032_0002
in which
R R2, R3, m and n are as defined in claim 1.
3. A compound according to claim 2 wherein, in formula (2), R3 is C-|-Ci2alkyl; or phenyl.
4. A compound according to claim 2 or 3, wherein R, and R2 are chlorine;
R3 is C C12alkyl; m is 2; and n is 1.
5. A compound according to claim 1 of the formula
in which
Rv R2, R4, m, n, p1 and p22 are as defined in claim 1.
6. A compound according to claim 1 of the formula
Figure imgf000033_0002
in which
R1f R2, n, m and p2 are as defined in claim 1.
7. A compound according to claim 1 of the formula
Figure imgf000033_0003
in which
V is a radical of the formula (1 g).
8. A process for the preparation of the compound of the formula (1 ), in which
Y is a radical of the formula (1 b);
R3 is Oj-C^alkyl; C^C^alkoxy; phenyl; phenyl-C1-C4alkyl; and
R R2, m and n are as defined in claim 1 , by esterification of the phenolic OH group of the compound of the formula
Figure imgf000034_0001
with an acyl halide compound.
9. A process for the preparation of the compounds of the formula (1 ), in which Y is a radical of the formula (1 a) or (1 c); and
R R2, m and n are as defined in claim 1 , by etherification of the phenolic OH group of the compound of the formula
Figure imgf000034_0002
with the corresponding halide compound.
10. A process for the antimicrobial finishing of organic material, which comprises adding at least one compound of the formula (1 ) thereto.
11. The use of the compounds according to any one of claims 1 to 7 for the antimicrobial finishing of polymeric materials.
12. A composition comprising
(A) an organic material to be antimicrobially finished and
(B) as antimicrobial active substance, at least one compound according to any one of claims 1 to 5.
13. The use of the compounds according to any one of claims 1 to 7 for finishing of undyed and dyed or printed fibre materials.
14. The use of the compounds according to any one of claims 1 to 7 for the disinfection of the skin, mucous membrane and hair in personal care products.
15. A personal care composition comprising at least one compound of the formula (1) and cosmetically tolerable carriers or auxiliaries.
PCT/EP1998/007997 1997-12-12 1998-12-09 O-derivatives of halogenated diphenyl ether compounds WO1999031036A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP98965241A EP1042265A2 (en) 1997-12-12 1998-12-09 O-derivatives of halogenated diphenyl ether compounds
AU20525/99A AU2052599A (en) 1997-12-12 1998-12-09 O-derivatives of halogenated diphenyl ether compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97810977 1997-12-12
EP97810977.5 1997-12-12

Publications (2)

Publication Number Publication Date
WO1999031036A2 true WO1999031036A2 (en) 1999-06-24
WO1999031036A3 WO1999031036A3 (en) 1999-11-04

Family

ID=8230519

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/007997 WO1999031036A2 (en) 1997-12-12 1998-12-09 O-derivatives of halogenated diphenyl ether compounds

Country Status (3)

Country Link
EP (1) EP1042265A2 (en)
AU (1) AU2052599A (en)
WO (1) WO1999031036A2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074834A1 (en) * 2000-03-30 2001-10-11 Bristol-Myers Squibb Company O-aryl glucoside sglt2 inhibitors and method
FR2839448A1 (en) * 2002-05-07 2003-11-14 Oreal The cosmetic or pharmaceutical use of esters of triclosan and of other antibacterial compounds in controlled release compositions to treat infective skin conditions such as acne, dermatitis, hair loss, dandruff and folliculitis
EP1845087A1 (en) * 2006-04-14 2007-10-17 Mutabilis SA Hydroxyphenyl derivatives and biological applications thereof
WO2008003606A1 (en) * 2006-07-05 2008-01-10 Ciba Holding Inc. Dihalogeno-hydroxydiphenylether as antimicrobials in water treatment
US20110171279A1 (en) * 2009-11-02 2011-07-14 Ndsu Research Foundation Polyethylenimine biocides
WO2011131773A1 (en) 2010-04-23 2011-10-27 Centre National De La Recherche Scientifique (C.N.R.S) Novel antimicrobial composition, use and preparation thereof
US8629210B2 (en) 2008-10-10 2014-01-14 Ndsu Research Foundation Zwitterionic/amphiphilic pentablock copolymers and coatings therefrom
JP2014522816A (en) * 2011-06-22 2014-09-08 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド Conjugate-based antifungal and antibacterial prodrugs
US9272985B2 (en) 2009-09-01 2016-03-01 Fab Pharma S.A.S. Antibacterial hydroxyphenyl compound
CN106349718A (en) * 2016-10-25 2017-01-25 齐鲁工业大学 Preparation method for antibacterial collagen
CN115536543A (en) * 2022-11-10 2022-12-30 贵州大学 Triclosan compound containing isopropanolamine structure and preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ780300A0 (en) * 2000-05-23 2000-06-22 Gillam, Ian Dr Dosage formula/guidelines for a sports antioxidant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629477A (en) * 1966-08-08 1971-12-21 Geigy Chem Corp Halogenated diphenyether-containing compositions and control of pests therewith
EP0761243A1 (en) * 1995-09-08 1997-03-12 Union Carbide Chemicals And Plastics Company, Inc. Biostatic coatings and processes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629477A (en) * 1966-08-08 1971-12-21 Geigy Chem Corp Halogenated diphenyether-containing compositions and control of pests therewith
EP0761243A1 (en) * 1995-09-08 1997-03-12 Union Carbide Chemicals And Plastics Company, Inc. Biostatic coatings and processes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
B.CARTÉ ET AL.: "Polybrominated Diphenyl Ethers from Dysidea Herbacea, Dysidea Cholera and Phyllospongia Foliascens." TETRAHEDRON., vol. 37, no. 13, 1981, pages 2335-2339, XP002065025 OXFORD GB *

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683056B2 (en) 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
AU2001249598B2 (en) * 2000-03-30 2006-09-07 Bristol-Myers Squibb Company O-aryl glucoside sglt2 inhibitors and method
KR100798203B1 (en) * 2000-03-30 2008-01-24 브리스톨-마이어스스퀴브컴파니 O-Aryl Glucoside SGLT2 Inhibitors and Method
JP4986202B2 (en) * 2000-03-30 2012-07-25 ブリストル−マイヤーズ スクイブ カンパニー O-aryl glucoside SGLT2 inhibitors and methods
WO2001074834A1 (en) * 2000-03-30 2001-10-11 Bristol-Myers Squibb Company O-aryl glucoside sglt2 inhibitors and method
FR2839448A1 (en) * 2002-05-07 2003-11-14 Oreal The cosmetic or pharmaceutical use of esters of triclosan and of other antibacterial compounds in controlled release compositions to treat infective skin conditions such as acne, dermatitis, hair loss, dandruff and folliculitis
US9309179B2 (en) 2006-04-14 2016-04-12 Fab Pharma Hydroxyphenyl derivatives and biological applications thereof
EP1845087A1 (en) * 2006-04-14 2007-10-17 Mutabilis SA Hydroxyphenyl derivatives and biological applications thereof
WO2007135562A2 (en) * 2006-04-14 2007-11-29 Mutabilis S.A. Hydroxyphenyl derivatives and biological applications thereof
US8722746B2 (en) 2006-04-14 2014-05-13 Fab Pharma S.A.S. Hydroxyphenyl derivatives and biological applications thereof
WO2007135562A3 (en) * 2006-04-14 2008-01-24 Mutabilis S A Hydroxyphenyl derivatives and biological applications thereof
WO2008003606A1 (en) * 2006-07-05 2008-01-10 Ciba Holding Inc. Dihalogeno-hydroxydiphenylether as antimicrobials in water treatment
US8629210B2 (en) 2008-10-10 2014-01-14 Ndsu Research Foundation Zwitterionic/amphiphilic pentablock copolymers and coatings therefrom
US9272985B2 (en) 2009-09-01 2016-03-01 Fab Pharma S.A.S. Antibacterial hydroxyphenyl compound
US20110171279A1 (en) * 2009-11-02 2011-07-14 Ndsu Research Foundation Polyethylenimine biocides
WO2011131773A1 (en) 2010-04-23 2011-10-27 Centre National De La Recherche Scientifique (C.N.R.S) Novel antimicrobial composition, use and preparation thereof
EP2386589A1 (en) 2010-04-23 2011-11-16 Centre National de la Recherche Scientifique (C.N.R.S) Novel antimicrobial composition, use and preparation thereof
JP2014522816A (en) * 2011-06-22 2014-09-08 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド Conjugate-based antifungal and antibacterial prodrugs
US9907812B2 (en) 2011-06-22 2018-03-06 Vyome Biosciences Pvt. Ltd. Conjugate-based antifungal and antibacterial prodrugs
CN106349718A (en) * 2016-10-25 2017-01-25 齐鲁工业大学 Preparation method for antibacterial collagen
CN115536543A (en) * 2022-11-10 2022-12-30 贵州大学 Triclosan compound containing isopropanolamine structure and preparation method and application thereof
CN115536543B (en) * 2022-11-10 2023-11-03 贵州大学 Triclosan compound containing isopropanolamine structure and preparation method and application thereof

Also Published As

Publication number Publication date
WO1999031036A3 (en) 1999-11-04
AU2052599A (en) 1999-07-05
EP1042265A2 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
DE60030318T2 (en) POLY (OXYALKYLATED) ALCOHOL SIDE THAT WAS CLOSED WITH ETHERS
EP1099689B1 (en) Functional alcohol releasing substance
WO1999031036A2 (en) O-derivatives of halogenated diphenyl ether compounds
US5187214A (en) Quaternary ammonium antistatic polymer compositions
US4904825A (en) Quaternary ammonium antistatic compounds
AU740539B2 (en) Improvements in or relating to organic compositions
KR100729543B1 (en) Hydroxydiphenyl ether compounds
US10905117B2 (en) Antimicrobial agent containing polyalkyleneimine derivative
JP2019218544A (en) Surfactant composition based on glycine betaine amide salts, process for preparing the same and uses thereof
DE60204509T2 (en) 4-amino-2- (2-pyridinyl) pyrimidines as microbicidal active substances
US3036084A (en) New oxazole compounds
US5053531A (en) Quaternary ammonium antistatic compounds
EP1119248A1 (en) Hydroxystilbene compounds used as microbicidal active substances
KR100672188B1 (en) Use of alkoxylated sugar esters in liquid aqueous softening compositions
KR20060052806A (en) Use of substituted 2,4-bis(alkylamino)pyrimidines or -quinazolines as antimicrobials
US6759423B2 (en) 4-Hydroxyisothiazole compounds
CA1126750A (en) Phosphoric acid triesters
EP1181090A1 (en) Use of a carboxylate alkyl polyglycoside surfactant to increase the foam of other anionic surfactants
US5786386A (en) Antibacterial and fungicidal agent
AU751838B2 (en) Diester amine adducts
EP1102536A1 (en) Microbicidal active substances
EP1103180A2 (en) Hydroxyphenylvinylthiazoles
US4973616A (en) Toluene sulfonate salts of 2-alkyl imidazolines
JPH0343483A (en) Silane composition for antibacterial deodorant spray
US3681249A (en) Unsymmetrical diphenyl carbonates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 1998965241

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09555869

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1998965241

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998965241

Country of ref document: EP